(Q38215514)

31 August 2017

Emerging therapies for noninfectious uveitis: what may be coming to the clinics (English)

1 reference

31 August 2017

1 reference

Jose R Maya

1

1 reference

31 August 2017

Mohammad A Sadiq

2

1 reference

31 August 2017

Liz J Zapata

3

1 reference

31 August 2017

Mostafa Hanout

4

1 reference

31 August 2017

Salman Sarwar

5

1 reference

31 August 2017

Nithya Rajagopalan

6

1 reference

31 August 2017

Kathleen E Guinn

7

1 reference

31 August 2017

Yasir J Sepah

8

1 reference

31 August 2017

Quan Dong Nguyen

9

1 reference

31 August 2017

24 April 2014

1 reference

31 August 2017

Journal of Ophthalmology

1 reference

31 August 2017

2014

1 reference

31 August 2017

310329

1 reference

Creative Commons Attribution 3.0 Unported

31 August 2017

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

The inhibitor of costimulation of T cells: abatacept

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Corticosteroid-sparing agents: conventional systemic immunosuppressants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Subconjunctival sirolimus in the treatment of diabetic macular edema

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

The efficacy of sirolimus in the treatment of patients with refractory uveitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Iodide iontophoresis as a treatment for dry eye syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Voclosporin as a treatment for noninfectious uveitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

IL-17 in the rheumatologist's line of sight

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Which are the antibodies to watch in 2012?

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020293

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2014%2F310329

IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease

21 January 2018

1 reference

12 December 2020

Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer

1 reference

12 December 2020

Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis

1 reference

12 December 2020

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

1 reference

12 December 2020

Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis

1 reference

12 December 2020

[Eye and corticosteroid's use]

1 reference

12 December 2020

Abatacept Use After Failure of Multiple Biologic Agents in Patients With Severe Rheumatoid Arthritis

1 reference

12 December 2020

Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials

1 reference

12 December 2020

Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye

1 reference

12 December 2020

What's New in Uveitis and Ocular Inflammation?

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/310329

1 reference

31 August 2017

1 reference

31 August 2017

PubMed publication ID

24868451

1 reference